Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Camille Lobry
Affiliation
INSERM U1170, Universite Paris Saclay
ORCID
Career Start Year
2007
Papers
34
H Index
21
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36585521
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
Leukemia
2023
35138899
Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.
Sci Adv
2022
35474100
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Leukemia
2022
35316324
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Blood
2022
35053311
Super-Enhancers Dysregulations in Hematological Malignancies.
Cells
2022
33408769
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia.
Theranostics
2021
32826232
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.
Cancer Discov
2020
31028249
Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.
Nat Commun
2019
31662298
Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.
Cancer Discov
2019
31453016
Analysis of <i>TET2</i> mutations in paroxysmal nocturnal hemoglobinuria (PNH).
Exp Hematol Oncol
2019
29403038
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.
Nat Cell Biol
2018
28292442
ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.
Cancer Cell
2017
28232365
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
Cancer Discov
2017
27135740
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Nat Med
2016
27270779
Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Nat Med
2016
27239026
Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation.
Cell Rep
2016
25965569
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.
Cancer Cell
2015
26450952
Restoring Ikaros's wings to solve a leukemia maze.
Blood
2015
26194287
Erratum: TET1 is a tumor suppressor of hematopoietic malignancy.
Nat Immunol
2015
25867473
TET1 is a tumor suppressor of hematopoietic malignancy.
Nat Immunol
2015
24608975
Notch signaling: switching an oncogene to a tumor suppressor.
Blood
2014
25150294
STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.
Blood
2014
23377202
Distinct TCR signaling pathways drive proliferation and cytokine production in T cells.
Nat Immunol
2013
23791481
In vivo mapping of notch pathway activity in normal and stress hematopoiesis.
Cell Stem Cell
2013
23359070
Notch pathway activation targets AML-initiating cell homeostasis and differentiation.
J Exp Med
2013
22547652
Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.
J Exp Med
2012
21030981
PHF6 mutations in adult acute myeloid leukemia.
Leukemia
2011
22109558
T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.
Proc Natl Acad Sci U S A
2011
21948802
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.
J Exp Med
2011
21562564
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.
Nature
2011
21723200
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Cancer Cell
2011
17213322
Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
Proc Natl Acad Sci U S A
2007
17433222
[New Bcl10 regulation mechanisms: a step in the comprehension of what has occurred in MALT lymphomas?].
Med Sci (Paris)
2007
17937895
[Regulation of NF-kappaB pathway in T lymphocytes].
Med Sci (Paris)
2007
1 - 34 of 34
Column Actions
Search
Recommended Authors
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
2011
Number of shared co-authors
0
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2009
Number of shared co-authors
2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2006
Number of shared co-authors
4
Marc A Kerenyi
Boston Children's Hospital, Harvard Medical School
Career Start Year
2006
Number of shared co-authors
0
Bastien Gerby
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
Career Start Year
2005
Number of shared co-authors
4
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
2
Michele Ceribelli
National Center for Advancing Translational Sciences
Career Start Year
2004
Number of shared co-authors
2
Aniruddha J Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2004
Number of shared co-authors
3
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year
2004
Number of shared co-authors
1
Robert S Welner
University of Alabama at Birmingham
Career Start Year
2002
Number of shared co-authors
1
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year
2001
Number of shared co-authors
0
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
3
Evan F Lind
Oregon Health & Science University
Career Start Year
1999
Number of shared co-authors
1
Katia Basso
Institute for Cancer Genetics, Columbia University
Career Start Year
1999
Number of shared co-authors
1
Ravindra Majeti
Stanford University School of Medicine
Career Start Year
1998
Number of shared co-authors
4
Charles G Mullighan
St Jude Children's Research Hospital
Career Start Year
1996
Number of shared co-authors
13
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
10
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
1
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
3
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
1991
Number of shared co-authors
3
Ricky W Johnstone
The University of Melbourne
Career Start Year
1990
Number of shared co-authors
3
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year
1989
Number of shared co-authors
2
Guy Sauvageau
Universite de Montreal
Career Start Year
1988
Number of shared co-authors
2
Tarik M??r??y
Institut de recherches cliniques de Montreal
Career Start Year
1985
Number of shared co-authors
0
Toshio Kitamura
The University of Tokyo.
Career Start Year
1984
Number of shared co-authors
2
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
1984
Number of shared co-authors
5
Louis M Staudt
National Cancer Institute, National Institutes of Health
Career Start Year
1983
Number of shared co-authors
5
Timothy J Ley
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
2
Daniel G Tenen
Harvard Stem Cell Institute, Harvard Medical School
Career Start Year
1975
Number of shared co-authors
9
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1970
Number of shared co-authors
10
row(s) 1 - 30 of 30
Collaborators
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Co-authored papers
4
Scott A Armstrong
Boston Children's Hospital
Co-authored papers
3
Robert K Bradley
Fred Hutchinson Cancer Research Center, University of Washington
Co-authored papers
3
Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers
3
Ari Melnick
Co-authored papers
3
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Co-authored papers
3
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Co-authored papers
2
Marie-Charlotte Laiguillon
INSERM U1170, Gustave Roussy Cancer Center and Universite Paris Saclay
Co-authored papers
2
Angela Su
The Broad Institute of MIT and Harvard
Co-authored papers
2
Heidi Dvinge
University of Wisconsin School of Medicine and Public Health
Co-authored papers
2
Gabriela Alexe
Dana-Farber Cancer Institute
Co-authored papers
2
Celine Lefebvre
The Scripps Research Institute
Co-authored papers
2
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Co-authored papers
2
Emmanuelle Clappier
Saint-Louis Hospital
Co-authored papers
2
Nina Fenouille
Universite Paris Cite, INSERM, CNRS
Co-authored papers
2
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers
2
Reinaldo Dal Bello
Universite Paris Cite, INSERM, CNRS
Co-authored papers
2
Gaetano Sodaro
Universite Paris Cite, INSERM, CNRS
Co-authored papers
2
Antoine Forget (CM4AI)
University of California San Francisco
Co-authored papers
2
Frank Ling
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers
1
Arnaud Jacquel
Universite Cote d'Azur, INSERM U5
Co-authored papers
1
Lucy A Godley
The University of Chicago
Co-authored papers
1
Nan Zhu
Shanghai General Hospital, Shanghai Jiaotong University
Co-authored papers
1
Il??ana Antony-Debr??
INSERM, France Villejuif Universite Paris-Saclay
Co-authored papers
1
Justine Penneroux
Universite Paris Cite, INSERM, CNRS
Co-authored papers
1
Mark M Davis
Co-authored papers
1
Jun Qi
Dana-Farber Cancer Institute
Co-authored papers
1
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Co-authored papers
1
Gael Fortin
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers
1
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Co-authored papers
1
1 - 30